People with asthma and obesity have a higher risk of death and hospitalization

Published Date: 06 Mar 2023

USA: Asthmatics affected by obesity have a higher risk of asthma attacks and longer hospital stays than non-obese asthmatics...

Read Full News

Latest News

Steroids May Ease Cough Severity, Not Rate, in Pneumonitis

Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.

GLP-1s May Curb Asthma Flares in Overweight and Obese Adults

New study suggests joint benefits for respiratory and weight management.

When Patients’ Sleep Disorders Are Linked to Dental Health

With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.

PAP Therapy May Reduce Pulmonary Pressures in Sleep Apnea

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon to Stock Lilly's New Weight-loss Pill At US Kiosks, Offer Same-day Delivery

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Treprostinil Can Slow Lung Decline in Pulmonary Fibrosis

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

Corticosteroids are associated with reduced cough severity and improved cough-related quality of life in patients with hypersensitivity pneumonitis, but they do not reduce objective cough frequency.

New study suggests joint benefits for respiratory and weight management.

With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

News All Time

Eosinophils, CC16, and the Role of COPD Biomarkers, with Francesca Polverino, MD, PhD Francesca Polverino, MD, PhD, Kevin Kunzmann

Polverino stresses the need for prospective analysis to validate CC16 and mucus plugs as viable biomarkers for COPD status.

Optimizing Lung Volume Reduction Surgery, with Charles Bakhos, MD, MBA, MS Charles Bakhos, MD, MBA, MS, Kevin Kunzmann

Bakhos explains the ideal patient population and strategies inherent to LVRS success.

Managing Perioperative, Postoperative Lung Cancer, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg explains how an emphasis on physical fitness prior to and after surgery can significantly better long-term outcomes.

New CHEST Recommendations Guide Biologic Use for Severe Asthma

New CHEST Recommendations Guide Biologic Use for Severe Asthma

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Recommended News For You

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma

DNA origami offers more accurate imaging in the fight against pancreatic cancer

Recommended Articles For You

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways 

The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape 

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

2.

FDA approves rivanetin as the first-line treatment for lung cancer.

3.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

4.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

5.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

1.

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential

2.

An Overview Of Daunorubicin: What Is It Used For And How Does It Work?

3.

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment

4.

Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians

5.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Understanding the causes of anemia in adults beyond nutritional deficiencies

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot